Replay available

Opko Health, Inc. (OPK) Q3 2025 Earnings Call

Opko Health, Inc. (NASDAQ: OPK) Q3 2025 earnings conference call, held 2025-10-29. Replay captured from the company's public earnings webcast.

Wed, October 29, 2025 at 4:30 PMendedReplay
Opko Health, Inc. (OPK) Q3 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Yvonne Briggs

Alliance Advisors, Investor Relations

Dr. Philip Frost

Chairman and Chief Executive Officer

Dr. Elias Zerhouni

Vice Chairman and President

Adam Logel

Chief Financial Officer

Maury Raycroft

Analyst, Jefferies

Dr. Gary Nabel

CEO, Modex

Yi Chen

Analyst, H.C. Wainwright

Kevin DeGieter

Analyst, Ladenburg Thalmann

Ted Tentoff

Analyst, Piper Sandler

Yael Jen

Analyst, Lidla & Co

Michael Petusky

Analyst, Barrington Research

Replay transcript excerpt

Good afternoon and welcome to the Opco Health Third Quarter 2025 Financial Results Conference Call. All participants will be in listen-only mode. Should you need assistance during the conference call, you may signal an operator by pressing star followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your telephone keypad. To withdraw your question, please press star, then two. Please note this event is being recorded. I would like to now turn the conference over to Yvonne Briggs. Please go ahead. Thank you, Operator, and good afternoon. This is Yvonne Briggs with Alliance Advisors IR. Thank you all for joining today's call to discuss Oplico Health's financial results for the third quarter of 2025. I'd like to remind you that any statements made during this call by management other than statements of historical fact will be considered forward-looking and, as such, are subject to risk and uncertainties that can materially affect the company's results. Those forward-looking statements include, without limitation, the various risks described in the company's SEC filings, including the annual report on Form 10-K for the year ended December 31, 2024, and subsequently filed SEC reports. Furthermore, this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, today, October 29, 2025. Except as required by law, OPCO undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this call. Regarding the format of today's call, Dr. Philip Frost, Chairman and Chief Executive Officer, will provide opening remarks. Dr. Elias Zerhouni, Vice Chairman and President, will then ...

More from Opko Health, Inc.